Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.

Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.

Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.

"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"

Kabooxa: New Cutting-Edge Software Assistant Bridges Gap Between AI and Monetization

All around the world, the proliferation of AI tools has decision-makers and business leaders asking each other “What are our needs and how can we use AI to meet them?” The engineers at Kabooxa have solved this contemporary business conundrum by asking another question: “What about an enterprise AI engine that you can leverage to boost performance and ROI?”

Medtronic Amplifies AiBLE Ecosystem with CD Horizon™ ModuLeX™ Spinal System for Deformity Procedures

“The CD Horizon ModuLeX™ spinal system has greatly improved my overall workflow for complex deformity surgery. Its modular design allows me to develop patient-specific, adaptable solutions to match the patient’s anatomy. With ModuLeX™, not only can you see more, but you can do more; the system allows me to be flexible in my approach. In my hands, the system improves my surgical efficiency and visibility of the surgical area, which helps me deliver a better standard of help for pediatric patients” said Dr. Nicholas Fletcher, Children’s Healthcare of Atlanta at Scottish Rite and Medtronic consultant.

Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future

Syncona: Resolution Therapeutics Raises £63.5 Million in Series B Financing | Appoints New Chair

Use of proceeds from the Series B financing will support the clinical entry and development of RTX001, with a Phase I/II trial expected to start in Q4 CY2024. Following this financing, Resolution Therapeutics is funded to deliver data from this trial, anticipated in CY2026, a key value inflection point with the potential to drive significant NAV growth for Syncona. Proceeds will also be used to develop the company’s manufacturing platform, expand the pre-clinical pipeline, and further strengthen the management team, following several key recent appointments, including Dr Amir Hefni as CEO, Simon Ramsden as CFO and Dr Clifford A. Brass as CMO.

Industry Expert Byline

Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies

TekniPlex Healthcare

TekniPlex Healthcare Acquires Seisa Medical

Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.

FDA Medical Device Updates

Our Experts - Byline Articles

Medical Imaging Technologies and Their Impact on Modern Healthcare

Healing Headlines, Transforming Lives: Hospitals in the News

Elucid Announces Fifth Medicare Administrative Contractor to Cover AI Coronary Plaque Analysis

“This latest expansion of coverage by Noridian means that even more patients could be positively impacted by PlaqueIQ, which offers the only non-invasive measurement of lipid-rich necrotic core, a vulnerable, high-risk component of plaque that can lead to heart attack and stroke,”4 said Kelly Huang, CEO of Elucid. “These recent decisions from five of the seven MACs recognize the importance of new technologies like ours that can help quantify and classify coronary artery plaque to help physicians reduce the clinical and economic burden of cardiovascular disease.”

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Executives on the Move

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers and Opportunities in the Evolving Medical Field

Nurses Corner: A Dedicated Space for Professional Insights and Resources

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.